Development of gene therapy for encapsulating peritoneal sclerosis by a chimeric DNA-RNA hammerhead ribozyme targeting TGF-β1 mRNA

Japanese Journal of Nephrology

Volumn 49, Issue 2, 2007, Pages 113-120

  Maruyama, Noriaki ^a   Fukuda, Noboru ^a   Okada, Kazuyoshi ^a   Matsumoto, Koichi ^b  

^a NIHON UNIVERSITY   (Japan)

^b NONE

Author keywords

Encapsulating peritoneal sclerosis; Gene therapy; Ribozyme; Transforming growth factor 1

Indexed keywords

ALCOHOL; CHLORHEXIDINE GLUCONATE; DNA RNA HAMMERHEAD RIBOZYME; FIBRONECTIN; MESSENGER RNA; RIBOZYME; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENCAPSULATING PERITONEAL SCLEROSIS; GENE THERAPY; NONHUMAN; PERITONEAL DISEASE; PROTEIN EXPRESSION; PROTEIN TARGETING; RAT; REAL TIME POLYMERASE CHAIN REACTION;

ABDOMINAL WALL; ANIMALS; DISEASE MODELS, ANIMAL; FIBRONECTINS; GENE THERAPY; MALE; PERITONEAL DIALYSIS; PERITONEUM; RATS; RATS, SPRAGUE-DAWLEY; RNA, CATALYTIC; RNA, MESSENGER; SCLEROSIS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 34047254138     PISSN: 03852385     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Annual Review, 2005 : 138-144.
2. Pollock C. Pathogenesis of peritoneal sclerosis. Int J Artif Organs 2005 ; 28(2) : 90-96.
3. Nakamura S, Niwa T. Advanced glycation end-products and peritoneal sclerosis. Semin Nephrol 2004 ; 24(5) : 502-505.
4. Io H, Hamada C, Ro Y, Ito Y, Hirahara I, Tomino Y. Morphologic changes of peritoneum and expression of VEGF in encapsulated peritoneal sclerosis rat models. Kidney Int 2004 ; 65(5) : 1927-1936.
5. Ignotz RA, Massague J. Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 1986 ; 261(9) : 4337-4345.
6. Fukuda N. Therapeutic application of ribozymes for cardiovascular disease. In : Levon Michael Khachigian (eds) Synthetic Nucleic Acids as Inhibitors of Gene Expression. Florida : CRC Press LLC, 2004 : 1-17.
7. 1 mRNA inhibits the exaggerated growth of vascular smooth muscle cells from spontaneously hypertensive rats. Cardiovasc Res 2000 ; 48 : 138-147.
8. 1 mRNA inhibits neointima formation in rat carotid artery after balloon injury. Eur J Pharmacol 2004 ; 483(2-3) : 207-214.
9. 1. J Periodontol 2005 ; 76 (8) : 1265-1274.
10. Offner FA, Feichtinger H, Stadlmann S, Obrist P, Marth C, Klingler P, Grage B, Schmahl M, Knabbe C. Transforming growth factor-β synthesis by human peritoneal mesothelial cells. Induction by interleukinl. Am J Pathol 1996 ; 148 (5) : 1679-1688.
11. Medcalf JF, Walls J, Pawluczyk IZ, Harris KP. Effects of glucose dialysate on extracellular matrix production by human peritoneal mesothelial cells (HPMC) : the role of TGF-β. Nephrol Dial Transplant 2001 ; 16(9) : 1885-1892.
12. Oh KH, Margetts PJ. Cytokines and growth factors involved in peritoneal fibrosis of peritoneal dialysis patients. Int J Artif Organs 2005 ; 28(2) : 129-134.
13. Ishii Y, Sawada T, Shimizu A, Tojimbara T, Nakajima I, Fuchinoue S, Teraoka S. An experimental sclerosing encapsulating peritonitis model in mice. Nephrol Dial Transplant 2001 ; 16(6) : 1262-1266.
14. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987 ; 162(1) : 156-159.
15. 1 to the rat peritoneum : effects on membrane function. J Am Soc Nephrol 2001 ; 12(10) : 2029-2039.
16. 1 induces epithelial mesenchymal transition in the rodent peritoneum. J Am Soc Nephrol 2005 ; 16(2) : 425-436.
17. Garosi G. Different aspects of peritoneal sclerosis. Contrib Nephrol 2003 ; 140 : 18-29.
18. Kawanishi H, Kawaguchi Y, Fukui H, Hara S, Imada A, Kubo H, Kin M, Nakamoto M, Ohira S, Shoji T. Encapsulating peritoneal sclerosis in Japan ; prospective multicenter survey. Am J Kidney Dis 2004 ; 44 : 729-737.
19. Japanese source